首页 > 产品 > Novel inhibitors
产品编号 产品名称 CAS No.
DC8940 Raltitrexed

Raltitrexed(ZD1694), an inhibitor of thymidylate synthase, is an antimetabolite drug used in cancer chemotherapy.

112887-68-0
DC9240 PS-47

1180676-33-8
DC9296 A-1331852

A-1331852 is a high affinity BH3 mimetic Ligand of BCL protein BCL-XL.

1430844-80-6
DC9298 thiotepa

N,N’N’-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group.

52-24-4
DC9308 Doravirine (MK-1439)

Doravirine (MK-1439) is a non-nucleoside reverse transcriptase inhibitor.

1338225-97-0
DC9330 AIM-100

AIM-100 is a small molecule inhibitor of Ack1 with an IC50 of 24 nM IC50 value: 24 nM [3] Target: Ack1 Ack1 inhibitor AIM-100 not only inhibited Ack1 activation but also suppressed AKT tyrosine phosphorylation, leading to cell cycle arrest in the G1 ph

873305-35-2
DC9335 AT7867

AT7867 is a potent ATP-competitive inhibitor of Akt1/2/3 and p70S6K/PKA with IC50 of 32 nM/17 nM/47 nM and 85 nM/20 nM, respectively; little activity outside the AGC kinase family.

857531-00-1
DC9354 Tigecycline

Tigecycline is a first-in-class, broad spectrum antibiotic with activity against antibiotic-resistant organisms.

220620-09-7
DC9373 5-TAMRA

The amine-reactive 5-TAMRA, SE and its conjugates yield bright, pH-insensitive orange-red fluorescence (approximate excitation/emission maxima ~546/579) with good photostability.

91809-66-4
DC9388 RS 504393

RS 504393 is a selective CCR2 chemokine receptor antagonist (IC50 values are 98 nM and > 100 μM for inhibition of human recombinant CCR2b and CCR1 receptors respectively).

300816-15-3
DC9394 LDC000067

LDC000067(LDC-067) is a highly specific CDK9 inhibitor with IC50 of 32.7 nM for CDK9/cyclin T1; displays 55/125/210/ >227/ >227-fold selectivity for CDK9 versus CDK2/1/4/6/7.

1073485-20-7
DC9402 Letermovir

AIC246 is a novel anti-CMV compound which targets the viral terminase complex and remains active against virus resistant to DNA polymerase inhibitors.

917389-32-3
DC9442 PF-04457845

PF-04457845 is a potent and exquisitely selective inhibitor of FAAH, with an IC50 of 7.2 nM, and both analgesic and antiinflammatory effects in animal studies comparable to naproxen.

1020315-31-4
DC9446 Y15

Y15 is a novel small molecule FAK phosphorylation inhibitor; specifically block phosphorylation of Y397-FAK and total phosphorylation of FAK.

4506-66-5
DC9459 SB 415286

SB 415286 is a potent and selective cell-permeable, ATP-competitive inhibitor of GSK3α with an IC50 value of 78 nM (similar potency for GSK3β) and a Ki value of 31 nM.

264218-23-7
DC9503 MI 2 (MALT1 inhibitor)

MI 2(MALT1 inhibitor) is a small molecule and irreversible inhibitor of MALT1 with IC50 of 5.84 uM(suppression of proliferation in ABCDLBCL).

1047953-91-2
DC9504 YH239-EE

YH239-EE, ethyl ester of the free carboxylic acid compound YH239, is a potent p53-MDM2 antagonizing and apoptosis-inducing agent

1364488-67-4
DC9505 Pifithrin-α (hydrobromide)

Pifithrin-α is an inhibitor of p53, inhibiting p53-dependent transactivation of p53-responsive genes.

63208-82-2
DC9536 Sertindole

Sertindole, a neuroleptic, is one of the newer antipsychotic medications available.

106516-24-9
DC9542 MPTP (hydrochloride)

MPTP HCl induced reduction in the DOPAC HVA/dopamine (DA) ratio and increase in striatal ascorbate (AS) oxidation in rats

23007-85-4
DC9545 Miglustat (hydrochloride)

Miglustat hydrochloride is an inhibitor of glucosylceramide synthase, primarily to treat Type I Gaucher disease (GD1).

210110-90-0
DC9574 A-317491 (sodium salt hydrate)

A-317491 is a non-nucleotide P2X3 and P2X2/3 receptor antagonist, which inhibits calcium flux mediated by the receptors.

475205-49-3
第 18 页 / 共 19 页第一页上一页下一页最末页转到